Novabase S.G.P.S [NBA] vs Corticeira Amorim [COR] Detailed Stock Comparison
Novabase S.G.P.S
Euronext
Loading...
Corticeira Amorim
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Novabase S.G.P.S wins in 4 metrics, Corticeira Amorim wins in 15 metrics, with 0 ties. Corticeira Amorim appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Novabase S.G.P.S | Corticeira Amorim | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 46.18 | 13.98 | Corticeira Amorim |
| Price-to-Book Ratio | 6.37 | 1.30 | Corticeira Amorim |
| Debt-to-Equity Ratio | 31.39 | 27.69 | Corticeira Amorim |
| PEG Ratio | 98.13 | 8.46 | Corticeira Amorim |
| EV/EBITDA | 27.19 | 8.21 | Corticeira Amorim |
| Profit Margin (TTM) | 6.62% | 7.68% | Corticeira Amorim |
| Operating Margin (TTM) | 8.43% | 12.84% | Corticeira Amorim |
| EBITDA Margin (TTM) | 8.43% | 12.84% | Corticeira Amorim |
| Return on Equity | 13.04% | 8.35% | Novabase S.G.P.S |
| Return on Assets (TTM) | 4.69% | 5.12% | Corticeira Amorim |
| Free Cash Flow (TTM) | $-2.99M | $79.19M | Corticeira Amorim |
| Dividend Yield | 18.24% | 4.12% | Novabase S.G.P.S |
| 1-Year Return | 37.72% | -17.11% | Novabase S.G.P.S |
| Price-to-Sales Ratio (TTM) | 2.30 | 1.09 | Corticeira Amorim |
| Enterprise Value | $280.76M | $1.24B | Corticeira Amorim |
| EV/Revenue Ratio | 2.17 | 1.36 | Corticeira Amorim |
| Gross Profit Margin (TTM) | N/A | 54.79% | N/A |
| Revenue per Share (TTM) | $4 | $7 | Corticeira Amorim |
| Earnings per Share (Diluted) | $0.17 | $0.53 | Corticeira Amorim |
| Beta (Stock Volatility) | 0.24 | 0.37 | Novabase S.G.P.S |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Novabase S.G.P.S vs Corticeira Amorim Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Novabase S.G.P.S | -0.63% | -0.63% | -1.88% | -9.77% | 6.80% | 33.05% |
| Corticeira Amorim | -1.46% | -1.85% | -4.26% | -5.73% | -10.18% | -7.61% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Novabase S.G.P.S | 37.72% | 68.45% | 137.88% | 247.35% | 263.43% | 263.43% |
| Corticeira Amorim | -17.11% | -25.75% | -29.43% | 58.67% | 436.96% | 436.96% |
Performance & Financial Health Analysis: Novabase S.G.P.S vs Corticeira Amorim
| Metric | NBA | COR |
|---|---|---|
| Market Information | ||
| Market Cap | €296.16M | €996.11M |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 1,076 | 92,999 |
| 90 Day Avg. Volume | 2,205 | 109,471 |
| Last Close | €7.85 | €7.41 |
| 52 Week Range | €5.55 - €10.40 | €7.02 - €9.15 |
| % from 52W High | -24.52% | -19.02% |
| All-Time High | €10.40 (Jun 03, 2025) | €13.30 (Jun 19, 2017) |
| % from All-Time High | -24.52% | -44.29% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.06% | -0.08% |
| Quarterly Earnings Growth | 0.76% | 0.00% |
| Financial Health | ||
| Profit Margin (TTM) | 0.07% | 0.08% |
| Operating Margin (TTM) | 0.08% | 0.13% |
| Return on Equity (TTM) | 0.13% | 0.08% |
| Debt to Equity (MRQ) | 31.39 | 27.69 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €1.23 | €5.71 |
| Cash per Share (MRQ) | €0.77 | €0.57 |
| Operating Cash Flow (TTM) | N/A | N/A |
| Levered Free Cash Flow (TTM) | €6.42M | €69.70M |
| Dividends | ||
| Last 12-Month Dividend Yield | 18.24% | 4.12% |
| Last 12-Month Dividend | €1.35 | €0.32 |
Valuation & Enterprise Metrics Analysis: Novabase S.G.P.S vs Corticeira Amorim
| Metric | NBA | COR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 46.18 | 13.98 |
| Forward P/E | 98.13 | 11.58 |
| PEG Ratio | 98.13 | 8.46 |
| Price to Sales (TTM) | 2.30 | 1.09 |
| Price to Book (MRQ) | 6.37 | 1.30 |
| Market Capitalization | ||
| Market Capitalization | €296.16M | €996.11M |
| Enterprise Value | €280.76M | €1.24B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.17 | 1.36 |
| Enterprise to EBITDA | 27.19 | 8.21 |
| Risk & Other Metrics | ||
| Beta | 0.24 | 0.37 |
| Book Value per Share (MRQ) | €1.23 | €5.71 |
Financial Statements Comparison: Novabase S.G.P.S vs Corticeira Amorim
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | NBA | COR |
|---|---|---|
| Revenue/Sales | N/A | €229.42M |
| Cost of Goods Sold | N/A | €103.71M |
| Gross Profit | N/A | €125.71M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | €25.13M |
| EBITDA | N/A | €43.11M |
| Pre-Tax Income | N/A | €24.13M |
| Income Tax | N/A | €5.35M |
| Net Income (Profit) | N/A | €18.79M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | NBA | COR |
|---|---|---|
| Cash & Equivalents | €62.75M | €75.37M |
| Total Current Assets | €119.32M | €790.22M |
| Total Current Liabilities | €54.16M | €303.76M |
| Long-Term Debt | €14.22M | €119.10M |
| Total Shareholders Equity | €84.89M | €852.19M |
| Retained Earnings | €6.42M | €16.42M |
| Property, Plant & Equipment | €9.27M | €432.19M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | NBA | COR |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | €-400,000 | €-4.52M |
| Free Cash Flow | €-2.13M | €34.84M |
| Debt Repayment | €-725,000 | €-37.66M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | NBA | COR |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 1,076 | 92,999 |
| Average Daily Volume (90 Day) | 2,205 | 109,471 |
| Shares Outstanding | 35.10M | 133.00M |
| Float Shares | 8.92M | 38.03M |
| % Held by Insiders | 0.74% | 0.71% |
| % Held by Institutions | 0.04% | 0.17% |
Dividend Analysis & Yield Comparison: Novabase S.G.P.S vs Corticeira Amorim
| Metric | NBA | COR |
|---|---|---|
| Last 12-Month Dividend | €1.35 | €0.32 |
| Last 12-Month Dividend Yield | 18.24% | 4.12% |
| 3-Year Avg Annual Dividend | €1.26 | €0.30 |
| 3-Year Avg Dividend Yield | 14.34% | 2.05% |
| 3-Year Total Dividends | €3.78 | €0.90 |
| Ex-Dividend Date | Jun 05, 2025 | May 26, 2025 |